Duquesne Family Office’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-122,700	Closed	-$6.27M	–	55
2024 Q4	$6.27M	Sell	122,700 -186,300	-60%	-$9.53M	0.17%	61
2024 Q3	$15.8M	Hold	309,000	–	–	0.53%	34
2024 Q2	$13.8M	Hold	309,000	–	–	0.47%	36
2024 Q1	$14.5M	Buy	+309,000	New	+$14.5M	0.33%	40